Companies Alto Neuroscience, Inc.
Alto Neuroscience (ANRO): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Email me Alto Neuroscience, Inc.’s executive pay brief as a PDF
It arrives in about 2 minutes, with every figure cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO pay, last three years
- $4,065,848FY2024
- $2,188,487FY2025
CEO total pay was $2,188,487 in fiscal 2025, down from $4,065,848 in fiscal 2024.
FY2025: salary $650,671 · bonus $220,000 · stock awards $0 · option awards $934,186
Order ANRO
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.
Executives and directors
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Amit Etkin | $650,671 | $220,000 | $0 | $934,186 | $358,072 | $0 | $25,558 | $2,188,487 |
| President, Chief Executive Officer, and Chair of the Board | ||||||||
| Nicholas Smith | 493,720 | 220,000 | 0 | 594,723 | 222,300 | 0 | 10,842 | 1,541,585 |
| Chief Financial Officer and Chief Business Officer | ||||||||
| Michael Hanley | 488,800 | 0 | 0 | 517,598 | 195,520 | 0 | 11,010 | 1,212,928 |
| Chief Operating Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Amit Etkin | $2,188,487 | $4,065,848 | — | ↓ −1,877,361 |
| Nicholas Smith | 1,541,585 | 1,995,964 | — | ↓ −454,379 |
| Michael Hanley | 1,212,928 | 2,442,628 | — | ↓ −1,229,700 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
The company's compensation philosophy is designed to align the interests of named executive officers with those of stockholders by providing a fixed base salary reflecting skill and market levels, annual incentive compensation based on individual and corporate performance, and equity-based awards that serve as retention measures and incentivize the achievement of corporate goals.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Aon Consulting, Inc. |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
Equity grants and outstanding awards
No plan-based awards are on file for this fiscal year.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Michael Hanley | RSU | 8,000 | — | $12,210 |
| Nicholas Smith | RSU | 24,670 | — | 9,163 |
| Amit Etkin | RSU | 25,243 | — | 9,377 |
| Nicholas Smith | RSU | 36,531 | — | 8,431 |
| Nicholas Smith | RSU | 39,375 | — | 19,688 |
| Michael Hanley | RSU | 74,417 | — | 113,583 |
| Amit Etkin | RSU | 97,563 | — | 48,782 |
| Michael Hanley | Option | 125,000 | 4.2 | — |
| Nicholas Smith | RSU | 134,886 | — | 67,443 |
| Nicholas Smith | Option | 135,000 | 4.2 | — |
| Amit Etkin | RSU | 164,859 | — | 82,431 |
| Amit Etkin | RSU | 215,000 | — | 107,502 |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Christopher Nixon CoxIndependent · Lead Independent Director · Audit · Compensation (Chair) · Nominating and Corporate Governance | $4,390 | — | $106,153 | — | — | $110,543 |
| Gwill YorkIndependent · Audit (Chair) · Compensation | 0 | — | 88,178 | — | — | 88,178 |
| Raymond Sanchez, M.DIndependent · Nominating and Corporate Governance | 8,682 | — | 76,222 | — | — | 84,904 |
| Andrew DreyfusIndependent · Audit · Compensation | 54,000 | — | 26,263 | — | — | 80,263 |
| Husseini Manji, M.DIndependent · Nominating and Corporate Governance (Chair) | 1,929 | — | 71,200 | — | — | 73,129 |
| Po Yu (Jeff) Chen, Ph.DIndependent · Departed during FY | 19,747 | — | 0 | — | — | 19,747 |
| Maha Radhakrishnan, M.DIndependent · Departed during FY | 17,906 | — | 0 | — | — | 17,906 |
| Amit Etkin, M.D., Ph.DEmployee director · Board Chair | — | — | — | — | — | 0 |
Board fee structure and ownership guideline
| Annual cash retainer | $40,000 |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 16,000 / 12,000 / 10,000 |
| Stock ownership guideline | — |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $106,654 |
| Equity awards (grant-date value) | $0 |
| All other compensation | $0 |
| Total cost of the board | $106,654 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Alto Neuroscience as a peer
Companies that benchmark against ANRO
1 company names ANRO as a compensation peer
- DiaMedica Therapeutics Inc.DMACFY2025
Each company listed discloses ANRO in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named ANRO in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Alto Neuroscience, Inc. | 2025 | Amit Etkin | $650,671 | $0 | $934,186 | $358,072 | $2,188,487 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Say-on-pay history and pay ratio
No say-on-pay vote is on file for this company.
CEO pay ratio
| Ratio (CEO : median employee) | — |
|---|---|
| CEO total compensation | — |
| Median employee compensation | — |
Insider trades since the proxy
No insider equity transactions reported since the proxy statement.
Sources (15 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Amit Etkin. DEF 14A, filed 2026-03-26. Section “Summary Compensation Table”. As printed: 2,188,487. View filing ↗
- Section 01, Nicholas Smith. DEF 14A, filed 2026-03-26. Section “Summary Compensation Table”. As printed: 1,541,585. View filing ↗
- Section 01, Michael Hanley. DEF 14A, filed 2026-03-26. Section “Summary Compensation Table”. As printed: 1,212,928. View filing ↗
- Section 07, pay ratio. 10-K, filed 2026-03-16. Section “CEO Pay Ratio”. As printed: —. View filing ↗
- Section 08, Christopher Nixon Cox. DEF 14A, filed 2026-03-26. Section “Director Compensation”. As printed: 110,543. View filing ↗
- Section 08, Gwill York. DEF 14A, filed 2026-03-26. Section “Director Compensation”. As printed: 88,178. View filing ↗
- Section 08, Raymond Sanchez, M.D. DEF 14A, filed 2026-03-26. Section “Director Compensation”. As printed: 84,904. View filing ↗
- Section 08, Andrew Dreyfus. DEF 14A, filed 2026-03-26. Section “Director Compensation”. As printed: 80,263. View filing ↗
- Section 08, Husseini Manji, M.D. DEF 14A, filed 2026-03-26. Section “Director Compensation”. As printed: 73,129. View filing ↗
- Section 08, Po Yu (Jeff) Chen, Ph.D. DEF 14A, filed 2026-03-26. Section “Director Compensation”. As printed: 19,747. View filing ↗
- Section 08, Maha Radhakrishnan, M.D. DEF 14A, filed 2026-03-26. Section “Director Compensation”. As printed: 17,906. View filing ↗
- Section 08, Amit Etkin, M.D., Ph.D. DEF 14A, filed 2026-03-26. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 09b board cost (computed). Computed. Cash 106,654 + equity 0 + all other 0 = 106,654, summed across the director compensation table rows.
- Alto Neuroscience, Inc. (subject), Section 10b CEO total. DEF 14A, filed 2026-03-26. CEO total compensation as printed in Alto Neuroscience, Inc.'s own proxy. As printed: 2,188,487. View filing ↗